EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?

Kexun Li, Jiapeng Yang, Ynchao Huang

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2024.02.024 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Kexun Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Lung Cancer of Yunnan Province, Department of Thoracic Surgery I, Cancer Center of Yunnan Province, Yunnan Cancer Hospital, The Thi…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 4 Literaturangaben. Gefördert von: National Clinical Key Specialty Project Foundation, Yunnan Provincial Science and Technology Department, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsNeoadjuvant TherapyEsophageal Squamous Cell CarcinomaHumansImmunotherapyEsophagectomyChemotherapy, AdjuvantTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapy, AdjuvantChemoradiotherapy

Autor:innen und Institutionen

  • Key Laboratory of Lung Cancer of Yunnan Province, Department of Thoracic Surgery I, Cancer Center of Yunnan Province, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.

Förderung

  • National Clinical Key Specialty Project Foundation
  • Yunnan Provincial Science and Technology Department
  • National Natural Science Foundation of China

Zitieren

APA

Li, K., Yang, J., & Huang, Y. (2024). Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.02.024

Vancouver

Li K, Yang J, Huang Y. Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2024.02.024

BibTeX
@article{Li2024,
  author = {Li, Kexun and Yang, Jiapeng and Huang, Ynchao},
  title = {Is neoadjuvant chemotherapy combined with immunotherapy really better than neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma?},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2024.02.024}
}
Kostenlos starten →